Figure 1From: Long-term efficacy of infliximab for refractory ulcerative colitis: results from a single center experience Clinical course and survival curves of UC patients treated with IFX. (A) Clinical course of UC patients who received IFX induction treatment. (B) Cumulative remission maintenance rate in 24 responders to IFX maintenance treatment, including IFX intensification. (C) Cumulative colectomy-free rate in patients who received IFX treatment during follow up.Back to article page